{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:33:13Z","timestamp":1774114393687,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1378\/chest.14-0758","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T09:31:40Z","timestamp":1409218300000},"page":"180-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Retrospective Review of Combined Sirolimus and Simvastatin Therapy in Lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"147","author":[{"given":"Angelo M.","family":"Taveira-DaSilva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Julien-Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.14-0758_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"NHLBI LAM Registry Group The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.14-0758_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.07-0898","article-title":"Lymphangioleiomyomatosis: a clinical update","volume":"133","author":"McCormack","year":"2008","journal-title":"Chest"},{"key":"10.1378\/chest.14-0758_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0032-1325159","article-title":"Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment","volume":"33","author":"Meraj","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1378\/chest.14-0758_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J Nippon Med Sch"},{"key":"10.1378\/chest.14-0758_bib5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1164\/ajrccm.164.8.2104095","article-title":"Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis","volume":"164","author":"Yu","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.14-0758_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1378\/chest.14-0758_bib7","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.14-0758_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","article-title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners","volume":"658","author":"Rosner","year":"2008","journal-title":"Mutat Res"},{"key":"10.1378\/chest.14-0758_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol Cell"},{"key":"10.1378\/chest.14-0758_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.molcel.2013.01.019","article-title":"Nutrient sensing, metabolism, and cell growth control","volume":"49","author":"Yuan","year":"2013","journal-title":"Mol Cell"},{"key":"10.1378\/chest.14-0758_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol Cell"},{"key":"10.1378\/chest.14-0758_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1378\/chest.14-0758_bib13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr Biol"},{"key":"10.1378\/chest.14-0758_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4161\/cc.8.3.7555","article-title":"PI3K\/mTORC1 activation in hamartoma syndromes: therapeutic prospects","volume":"8","author":"Krymskaya","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1378\/chest.14-0758_bib15","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.C300226200","article-title":"Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin-and farnesylation-dependent manner","volume":"278","author":"Castro","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1378\/chest.14-0758_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.14-0758_bib17","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One"},{"key":"10.1378\/chest.14-0758_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1378\/chest.14-0758_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.14-0758_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.14-0758_bib21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.14-0758_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1378\/chest.14-0758_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"10.1378\/chest.14-0758_bib24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/MCB.00782-08","article-title":"Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin","volume":"29","author":"Toschi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1378\/chest.14-0758_bib25","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/MCB.01061-10","article-title":"mTORC2 is required for proliferation and survival of TSC2-null cells","volume":"31","author":"Goncharova","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1378\/chest.14-0758_bib26","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis -a wolf in sheep's clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.14-0758_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1165\/rcmb.2013-0203RC","article-title":"Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling","volume":"49","author":"Atochina-Vasserman","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1378\/chest.14-0758_bib28","doi-asserted-by":"crossref","first-page":"9878","DOI":"10.1158\/0008-5472.CAN-07-1394","article-title":"Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR\/S6 kinase activity","volume":"67","author":"Finlay","year":"2007","journal-title":"Cancer Res"},{"key":"10.1378\/chest.14-0758_bib29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1158\/1535-7163.MCT-09-0055","article-title":"Renal and liver tumors in Tsc2(+\/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"8","author":"Finlay","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1378\/chest.14-0758_bib30","doi-asserted-by":"crossref","first-page":"154ra134","DOI":"10.1126\/scitranslmed.3003840","article-title":"Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)","volume":"4","author":"Goncharova","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1378\/chest.14-0758_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1183\/09031936.00012709","article-title":"Statins in lymphangioleiomyomatosis: a word of caution","volume":"34","author":"El-Chemaly","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.14-0758_bib32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215302488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215302488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:38:34Z","timestamp":1757918314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215302488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0012369215302488"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-0758","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective Review of Combined Sirolimus and Simvastatin Therapy in Lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.14-0758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}